|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 113, Issue 3 867-878, Copyright © 1991 by Company of Biologists
JOURNAL ARTICLES |
SD Robinson, GB Silberstein, AB Roberts, KC Flanders and CW Daniel
Department of Biology, Sinsheimer Laboratories, University of California, Santa Cruz 95064.
Transforming Growth Factor-beta 1 (TGF-beta 1) was previously shown to inhibit reversibly the growth of mouse mammary ducts when administered in vivo by miniature slow-release plastic implants. We now report a comparative analysis of three TGF-beta isoforms with respect to gene expression and localization of protein products within the mouse mammary gland. Our studies revealed overlapping expression patterns of TGF-beta 1, TGF-beta 2 and TGF-beta 3 within the epithelium of the actively-growing mammary end buds during branching morphogenesis, as well as within the epithelium of growth-quiescent ducts. However, TGF-beta 3 was the only isoform detected in myoepithelial progenitor cells (cap cells) of the growing end buds and myoepithelial cells of the mature ducts. During pregnancy, TGF-beta 2 and TGF-beta 3 transcripts increased to high levels, in contrast to TGF-beta 1 transcripts which were moderately abundant; TGF-beta 2 was significantly transcribed only during pregnancy. Molecular hybridization in situ revealed overlapping patterns of expression for the three TGF-beta isoforms during alveolar morphogenesis, but showed that, in contrast to the patterns of TGF-beta 1 and TGF-beta 2 expression, TGF-beta 3 is expressed more heavily in ducts than in alveoli during pregnancy. Developing alveolar tissue and its associated ducts displayed striking TGF-beta 3 immunoreactivity which was greatly reduced during lactation. All three isoforms showed dramatically reduced expression in lactating tissue. The biological effects of active, exogenous TGF-beta 2 and TGF-beta 3 were tested with slow-release plastic implants. These isoforms, like TGF-beta 1, inhibited mammary ductal elongation in situ by causing the disappearance of the proliferating stem cell layer (cap cells) and rapid involution of ductal end buds. None of the isoforms were active in inhibiting alveolar morphogenesis. We conclude that under the limited conditions of these tests, the three mammalian isoforms are functionally equivalent. However, striking differences in patterns of gene expression and in the distribution of immunoreactive peptides suggest that TGF-beta isoforms may have distinct roles in mammary growth regulation, morphogenesis and functional differentiation.
This article has been cited by other articles:
![]() |
E. Cocolakis, M. Dai, L. Drevet, J. Ho, E. Haines, S. Ali, and J.-J. Lebrun Smad Signaling Antagonizes STAT5-mediated Gene Transcription and Mammary Epithelial Cell Differentiation J. Biol. Chem., January 18, 2008; 283(3): 1293 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C Fleisch, C. A Maxwell, and M.-H. Barcellos-Hoff The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs. Endocr. Relat. Cancer, June 1, 2006; 13(2): 379 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Serra and M R Crowley Mouse models of transforming growth factor {beta} impact in breast development and cancer Endocr. Relat. Cancer, December 1, 2005; 12(4): 749 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Parmar and G. R Cunha Epithelial-stromal interactions in the mouse and human mammary gland in vivo Endocr. Relat. Cancer, September 1, 2004; 11(3): 437 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Musters, K. Coughlan, T. McFadden, R. Maple, T. Mulvey, and K. Plaut Exogenous TGF-{beta}1 Promotes Stromal Development in the Heifer Mammary Gland J Dairy Sci, April 1, 2004; 87(4): 896 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Muraoka, Y. Koh, L. R. Roebuck, M. E. Sanders, D. Brantley-Sieders, A. E. Gorska, H. L. Moses, and C. L. Arteaga Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor {beta}1 Mol. Cell. Biol., December 1, 2003; 23(23): 8691 - 8703. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Gorska, R. A. Jensen, Y. Shyr, M. E. Aakre, N. A. Bhowmick, and H. L. Moses Transgenic Mice Expressing a Dominant-Negative Mutant Type II Transforming Growth Factor-{beta} Receptor Exhibit Impaired Mammary Development and Enhanced Mammary Tumor Formation Am. J. Pathol., October 1, 2003; 163(4): 1539 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Siegel, W. Shu, and J. Massague Mad Upregulation and Id2 Repression Accompany Transforming Growth Factor (TGF)-{beta}-mediated Epithelial Cell Growth Suppression J. Biol. Chem., September 12, 2003; 278(37): 35444 - 35450. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Jeruss, C. D. Sturgis, A. W. Rademaker, and T. K. Woodruff Down-Regulation of Activin, Activin Receptors, and Smads in High-Grade Breast Cancer Cancer Res., July 1, 2003; 63(13): 3783 - 3790. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Plaut, A. J. Dean, T. A. Patnode, and T. M. Casey Effect of Transforming Growth Factor-beta (TGF-{beta}) on Mammary Development J Dairy Sci, July 1, 2003; 86(13_suppl): E16 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Ewan, G. Shyamala, S. A. Ravani, Y. Tang, R. Akhurst, L. Wakefield, and M. H. Barcellos-Hoff Latent Transforming Growth Factor-{beta} Activation in Mammary Gland : Regulation by Ovarian Hormones Affects Ductal and Alveolar Proliferation Am. J. Pathol., June 1, 2002; 160(6): 2081 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-a. Yang, B. Tang, G. Robinson, L. Hennighausen, S. G. Brodie, C.-X. Deng, and L. M. Wakefield Smad3 in the Mammary Epithelium Has a Nonredundant Role in the Induction of Apoptosis, but not in the Regulation of Proliferation or Differentiation by Transforming Growth Factor-{beta} Cell Growth Differ., March 1, 2002; 13(3): 123 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Mathura Jr, N. Jafari, J. T. Chang, S. F. Hackett, K. J. Wahlin, N. G. Della, N. Okamoto, D. J. Zack, and P. A. Campochiaro Bone Morphogenetic Proteins-2 and -4: Negative Growth Regulators in Adult Retinal Pigmented Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 592 - 600. [Abstract] [Full Text] |
||||
![]() |
L. Lund, S. Bjorn, M. Sternlicht, B. Nielsen, H Solberg, P. Usher, R Osterby, I. Christensen, R. Stephens, T. Bugge, et al. Lactational competence and involution of the mouse mammary gland require plasminogen Development, January 10, 2000; 127(20): 4481 - 4492. [Abstract] [PDF] |
||||
![]() |
A. Nguyen and J. Pollard Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution Development, January 7, 2000; 127(14): 3107 - 3118. [Abstract] [PDF] |
||||
![]() |
V Gouon-Evans, M. Rothenberg, and J. Pollard Postnatal mammary gland development requires macrophages and eosinophils Development, January 6, 2000; 127(11): 2269 - 2282. [Abstract] [PDF] |
||||
![]() |
P Batard, M. Monier, N Fortunel, K Ducos, P Sansilvestri-Morel, T Phan, A Hatzfeld, and J. Hatzfeld TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation J. Cell Sci., January 2, 2000; 113(3): 383 - 390. [Abstract] [PDF] |
||||
![]() |
E Piek, A Moustakas, A Kurisaki, C. Heldin, and P ten Dijke TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells J. Cell Sci., January 12, 1999; 112(24): 4557 - 4568. [Abstract] [PDF] |
||||
![]() |
M. M. Richert and T. L. Wood The Insulin-Like Growth Factors (IGF) and IGF Type I Receptor during Postnatal Growth of the Murine Mammary Gland: Sites of Messenger Ribonucleic Acid Expression and Potential Functions Endocrinology, January 1, 1999; 140(1): 454 - 461. [Abstract] [Full Text] |
||||
![]() |
C. Niemann, V. Brinkmann, E. Spitzer, G. Hartmann, M. Sachs, H. Naundorf, and W. Birchmeier Reconstitution of Mammary Gland Development In Vitro: Requirement of c-met and c-erbB2 Signaling for Branching and Alveolar Morphogenesis J. Cell Biol., October 19, 1998; 143(2): 533 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Toda, S. Matsumura, N. Fujitani, T. Nishimura, N. Yonemitsu, and H. Sugihara Transforming Growth Factor-{beta}1 Induces a Mesenchyme-Like Cell Shape without Epithelial Polarization in Thyrocytes and Inhibits Thyroid Folliculogenesis in Collagen Gel Culture Endocrinology, December 1, 1997; 138(12): 5561 - 5575. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Koli, T. T. Ramsey, Y. Ko, T. C. Dugger, M. G. Brattain, and C. L. Arteaga Blockade of Transforming Growth Factor-beta Signaling Does Not Abrogate Antiestrogen-induced Growth Inhibition of Human Breast Carcinoma Cells J. Biol. Chem., March 28, 1997; 272(13): 8296 - 8302. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Woo, H. H. Cha, K. L. Singer, and G. L. Firestone Antagonistic Regulation of Tight Junction Dynamics by Glucocorticoids and Transforming Growth Factor-beta in Mouse Mammary Epithelial Cells J. Biol. Chem., January 5, 1996; 271(1): 404 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lund, J Romer, N Thomasset, H Solberg, C Pyke, M. Bissell, K Dano, and Z Werb Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways Development, January 1, 1996; 122(1): 181 - 193. [Abstract] [PDF] |
||||
![]() |
J. Wysolmerski, J. McCaughern-Carucci, A. Daifotis, A. Broadus, and W. Philbrick Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development Development, January 11, 1995; 121(11): 3539 - 3547. [Abstract] [PDF] |
||||
![]() |
B Niranjan, L Buluwela, J Yant, N Perusinghe, A Atherton, D Phippard, T Dale, B Gusterson, and T Kamalati HGF/SF: a potent cytokine for mammary growth, morphogenesis and development Development, January 9, 1995; 121(9): 2897 - 2908. [Abstract] [PDF] |
||||
![]() |
G Wirl, M Hermann, P Ekblom, and R Fassler Mammary epithelial cell differentiation in vitro is regulated by an interplay of EGF action and tenascin-C downregulation J. Cell Sci., January 6, 1995; 108(6): 2445 - 2456. [Abstract] [PDF] |
||||
![]() |
D F Pierce, M D Johnson, Y Matsui, S D Robinson, L I Gold, A F Purchio, C W Daniel, B L Hogan, and H L Moses Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1. Genes & Dev., December 1, 1993; 7(12a): 2308 - 2317. [Abstract] [PDF] |
||||